Rethinking 30-day mortality risk after radical prostatectomy

被引:11
作者
Alibhai, Shabbir M. H.
Leach, Marc
Tomlinson, George
Krahn, Murray D.
Fleshner, Neil
Naglie, Gary
机构
[1] Univ Toronto, Hlth Network, Div Gen Internal Med & Clin Epidemiol, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[4] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[5] Univ Toronto, Dept Surg, Toronto, ON, Canada
[6] Univ Toronto, Inst Rehabil, Geriatr Program, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.urology.2006.06.016
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Although radical prostatectomy (RP) is associated with greater 30-day mortality in older men, the magnitude of the excess risk in older age groups compared with younger ones has not been well characterized. Methods. Using data from the Ontario Cancer Registry, we identified 11,010 men who underwent RP from 1990 to 1999 in Ontario, Canada and compared the 30-day mortality risk immediately after RP with the 1-month mortality risk in the same population of men 7 to 12 months after RP and that of an age-matched general population of men. Results. Overall, 53 men (0.48%) died within 30 days of surgery. The absolute excess 30-day mortality risk associated with RP was 0.18%, 0.51%, and 0.59% for men aged 50 to 59, 60 to 69, and 70 to 79 years, respectively, and was similar for men aged 60 to 69 and 70 to 79 years (P > 0.05). The relative mortality risk within 30 days of RP was approximately nine times the baseline risk (95% confidence interval 3 to 38) and was similar for men in all three age groups (P > 0.05). Conclusions. The results of our study indicate that men aged 70 to 79 years do not have a greater absolute excess or relative risk of 30-day mortality after RP compared with men aged 60 to 69 years.
引用
收藏
页码:1057 / 1060
页数:4
相关论文
共 23 条
[1]   Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer [J].
Albertsen, PC ;
Hanley, JA ;
Gleason, DF ;
Barry, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :975-980
[2]   Is there age bias in the treatment of localized prostate carcinoma? [J].
Alibhai, SMH ;
Krahn, MD ;
Cohen, MM ;
Fleshner, NE ;
Tomlinson, GA ;
Naglie, G .
CANCER, 2004, 100 (01) :72-81
[3]   Do older men benefit from curative therapy of localized prostate cancer? [J].
Alibhai, SMH ;
Naglie, G ;
Nam, R ;
Trachtenberg, J ;
Krohn, MD .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3318-3327
[4]   Examining the location and cause of death within 30 days of radical prostatectomy [J].
Alibhai, SMH ;
Leach, M ;
Tomlinson, G .
BJU INTERNATIONAL, 2005, 95 (04) :541-544
[5]   30-day mortality and major complications after radical prostatectomy: Influence of age and comorbidity [J].
Alibhai, SMH ;
Leach, M ;
Tomlinson, G ;
Krahn, MD ;
Fleshner, N ;
Holowaty, E ;
Naglie, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20) :1525-1532
[6]   Variations in morbidity after radical prostatectomy. [J].
Begg, CB ;
Riedel, ER ;
Bach, PB ;
Kattan, MW ;
Schrag, D ;
Warren, JL ;
Scardino, PT .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) :1138-1144
[7]   Radical prostatectomy versus watchful waiting in early prostate cancer [J].
Bill-Axelson, A ;
Holmberg, L ;
Ruutu, M ;
Häggman, M ;
Andersson, SO ;
Bratell, S ;
Spångberg, A ;
Busch, C ;
Nordling, S ;
Garmo, H ;
Palmgren, J ;
Adami, HO ;
Norlén, BJ ;
Johansson, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[10]   A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer [J].
Holmberg, L ;
Bill-Axelson, A ;
Helgesen, F ;
Salo, JO ;
Folmerz, P ;
Häggman, M ;
Andersson, S ;
Spångberg, A ;
Busch, C ;
Nordling, S ;
Palmgren, J ;
Adami, HO ;
Johansson, J ;
Norlén, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (11) :781-789